Selected research
Industry Growth & Trends
Global Sodium Picosulfate Oral Drug Industry Growth and Trends Forecast to 2032
Market perspective
The global Sodium Picosulfate Oral Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Sodium Picosulfate Oral Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Sodium Picosulfate Oral Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Sodium Picosulfate Oral Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Sodium Picosulfate Oral Drug include Yingke, Takeda Pharmaceuticals, Sun Pharmaceutical, Shanghai Fosun, Sanofi, Chengji Pharm, Rakshit Drugs, Kreative Organics and Ferring Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Sodium Picosulfate Oral Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Sodium Picosulfate Oral Drug market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Sodium Picosulfate Oral Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Sodium Picosulfate Oral Drug.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Sodium Picosulfate Oral Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Sodium Picosulfate Oral Drug Market by Company
Yingke
Takeda Pharmaceuticals
Sun Pharmaceutical
Shanghai Fosun
Sanofi
Chengji Pharm
Rakshit Drugs
Kreative Organics
Ferring Pharmaceuticals
Dishman Carbogen Amcis
Cambrex
Bidachem
Atom Pharma
Actylis
Sodium Picosulfate Oral Drug Segment by Type
Capsule
Tablet
Solution
Sodium Picosulfate Oral Drug Segment by Application
Constipation Treatment
Post-Surgical Bowel Regulation
Sodium Picosulfate Oral Drug Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sodium Picosulfate Oral Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sodium Picosulfate Oral Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sodium Picosulfate Oral Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sodium Picosulfate Oral Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Sodium Picosulfate Oral Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Capsule
- Tablet
- Solution
Applications
- Constipation Treatment
- Post-Surgical Bowel Regulation
Companies covered
- Yingke
- Takeda Pharmaceuticals
- Sun Pharmaceutical
- Shanghai Fosun
- Sanofi
- Chengji Pharm
- Rakshit Drugs
- Kreative Organics
- Ferring Pharmaceuticals
- Dishman Carbogen Amcis
- Cambrex
- Bidachem
- Atom Pharma
- Actylis
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Sodium Picosulfate Oral Drug Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Sodium Picosulfate Oral Drug Sales Estimates and Forecasts (2021-2032)
- 1.3 Sodium Picosulfate Oral Drug Market by Type
- 1.3.1 Capsule
- 1.3.2 Tablet
- 1.3.3 Solution
- 1.4 Global Sodium Picosulfate Oral Drug Market Size by Type
- 1.4.1 Global Sodium Picosulfate Oral Drug Market Size Overview by Type (2021-2032)
- 1.4.2 Global Sodium Picosulfate Oral Drug Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Sodium Picosulfate Oral Drug Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Sodium Picosulfate Oral Drug Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Sodium Picosulfate Oral Drug Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Sodium Picosulfate Oral Drug Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Sodium Picosulfate Oral Drug Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Sodium Picosulfate Oral Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Sodium Picosulfate Oral Drug Industry Trends
- 2.2 Sodium Picosulfate Oral Drug Industry Drivers
- 2.3 Sodium Picosulfate Oral Drug Industry Opportunities and Challenges
- 2.4 Sodium Picosulfate Oral Drug Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Sodium Picosulfate Oral Drug Revenue (2021-2026)
- 3.2 Global Top Players by Sodium Picosulfate Oral Drug Sales (2021-2026)
- 3.3 Global Top Players by Sodium Picosulfate Oral Drug Price (2021-2026)
- 3.4 Global Sodium Picosulfate Oral Drug Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Sodium Picosulfate Oral Drug Major Company Production Sites & Headquarters
- 3.6 Global Sodium Picosulfate Oral Drug Company, Product Type & Application
- 3.7 Global Sodium Picosulfate Oral Drug Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Sodium Picosulfate Oral Drug Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Sodium Picosulfate Oral Drug Players Market Share by Revenue in 2025
- 3.8.3 2025 Sodium Picosulfate Oral Drug Tier 1, Tier 2, and Tier 3
4 Sodium Picosulfate Oral Drug Regional Status and Outlook
- 4.1 Global Sodium Picosulfate Oral Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Sodium Picosulfate Oral Drug Historic Market Size by Region
- 4.2.1 Global Sodium Picosulfate Oral Drug Sales in Volume by Region (2021-2026)
- 4.2.2 Global Sodium Picosulfate Oral Drug Sales in Value by Region (2021-2026)
- 4.2.3 Global Sodium Picosulfate Oral Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Sodium Picosulfate Oral Drug Forecasted Market Size by Region
- 4.3.1 Global Sodium Picosulfate Oral Drug Sales in Volume by Region (2027-2032)
- 4.3.2 Global Sodium Picosulfate Oral Drug Sales in Value by Region (2027-2032)
- 4.3.3 Global Sodium Picosulfate Oral Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Sodium Picosulfate Oral Drug by Application
- 5.1 Sodium Picosulfate Oral Drug Market by Application
- 5.1.1 Constipation Treatment
- 5.1.2 Post-Surgical Bowel Regulation
- 5.2 Global Sodium Picosulfate Oral Drug Market Size by Application
- 5.2.1 Global Sodium Picosulfate Oral Drug Market Size Overview by Application (2021-2032)
- 5.2.2 Global Sodium Picosulfate Oral Drug Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Sodium Picosulfate Oral Drug Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Sodium Picosulfate Oral Drug Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Sodium Picosulfate Oral Drug Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Sodium Picosulfate Oral Drug Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Sodium Picosulfate Oral Drug Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Sodium Picosulfate Oral Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Yingke
- 6.1.1 Yingke Company Information
- 6.1.2 Yingke Business Overview
- 6.1.3 Yingke Sodium Picosulfate Oral Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Yingke Sodium Picosulfate Oral Drug Product Portfolio
- 6.1.5 Yingke Recent Developments
- 6.2 Takeda Pharmaceuticals
- 6.2.1 Takeda Pharmaceuticals Company Information
- 6.2.2 Takeda Pharmaceuticals Business Overview
- 6.2.3 Takeda Pharmaceuticals Sodium Picosulfate Oral Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Takeda Pharmaceuticals Sodium Picosulfate Oral Drug Product Portfolio
- 6.2.5 Takeda Pharmaceuticals Recent Developments
- 6.3 Sun Pharmaceutical
- 6.3.1 Sun Pharmaceutical Company Information
- 6.3.2 Sun Pharmaceutical Business Overview
- 6.3.3 Sun Pharmaceutical Sodium Picosulfate Oral Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Sun Pharmaceutical Sodium Picosulfate Oral Drug Product Portfolio
- 6.3.5 Sun Pharmaceutical Recent Developments
- 6.4 Shanghai Fosun
- 6.4.1 Shanghai Fosun Company Information
- 6.4.2 Shanghai Fosun Business Overview
- 6.4.3 Shanghai Fosun Sodium Picosulfate Oral Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Shanghai Fosun Sodium Picosulfate Oral Drug Product Portfolio
- 6.4.5 Shanghai Fosun Recent Developments
- 6.5 Sanofi
- 6.5.1 Sanofi Company Information
- 6.5.2 Sanofi Business Overview
- 6.5.3 Sanofi Sodium Picosulfate Oral Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Sanofi Sodium Picosulfate Oral Drug Product Portfolio
- 6.5.5 Sanofi Recent Developments
- 6.6 Chengji Pharm
- 6.6.1 Chengji Pharm Company Information
- 6.6.2 Chengji Pharm Business Overview
- 6.6.3 Chengji Pharm Sodium Picosulfate Oral Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Chengji Pharm Sodium Picosulfate Oral Drug Product Portfolio
- 6.6.5 Chengji Pharm Recent Developments
- 6.7 Rakshit Drugs
- 6.7.1 Rakshit Drugs Company Information
- 6.7.2 Rakshit Drugs Business Overview
- 6.7.3 Rakshit Drugs Sodium Picosulfate Oral Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Rakshit Drugs Sodium Picosulfate Oral Drug Product Portfolio
- 6.7.5 Rakshit Drugs Recent Developments
- 6.8 Kreative Organics
- 6.8.1 Kreative Organics Company Information
- 6.8.2 Kreative Organics Business Overview
- 6.8.3 Kreative Organics Sodium Picosulfate Oral Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Kreative Organics Sodium Picosulfate Oral Drug Product Portfolio
- 6.8.5 Kreative Organics Recent Developments
- 6.9 Ferring Pharmaceuticals
- 6.9.1 Ferring Pharmaceuticals Company Information
- 6.9.2 Ferring Pharmaceuticals Business Overview
- 6.9.3 Ferring Pharmaceuticals Sodium Picosulfate Oral Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Ferring Pharmaceuticals Sodium Picosulfate Oral Drug Product Portfolio
- 6.9.5 Ferring Pharmaceuticals Recent Developments
- 6.10 Dishman Carbogen Amcis
- 6.10.1 Dishman Carbogen Amcis Company Information
- 6.10.2 Dishman Carbogen Amcis Business Overview
- 6.10.3 Dishman Carbogen Amcis Sodium Picosulfate Oral Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Dishman Carbogen Amcis Sodium Picosulfate Oral Drug Product Portfolio
- 6.10.5 Dishman Carbogen Amcis Recent Developments
- 6.11 Cambrex
- 6.11.1 Cambrex Company Information
- 6.11.2 Cambrex Business Overview
- 6.11.3 Cambrex Sodium Picosulfate Oral Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Cambrex Sodium Picosulfate Oral Drug Product Portfolio
- 6.11.5 Cambrex Recent Developments
- 6.12 Bidachem
- 6.12.1 Bidachem Company Information
- 6.12.2 Bidachem Business Overview
- 6.12.3 Bidachem Sodium Picosulfate Oral Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Bidachem Sodium Picosulfate Oral Drug Product Portfolio
- 6.12.5 Bidachem Recent Developments
- 6.13 Atom Pharma
- 6.13.1 Atom Pharma Company Information
- 6.13.2 Atom Pharma Business Overview
- 6.13.3 Atom Pharma Sodium Picosulfate Oral Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Atom Pharma Sodium Picosulfate Oral Drug Product Portfolio
- 6.13.5 Atom Pharma Recent Developments
- 6.14 Actylis
- 6.14.1 Actylis Company Information
- 6.14.2 Actylis Business Overview
- 6.14.3 Actylis Sodium Picosulfate Oral Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Actylis Sodium Picosulfate Oral Drug Product Portfolio
- 6.14.5 Actylis Recent Developments
7 North America by Country
- 7.1 North America Sodium Picosulfate Oral Drug Sales by Country
- 7.1.1 North America Sodium Picosulfate Oral Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Sodium Picosulfate Oral Drug Sales by Country (2021-2026)
- 7.1.3 North America Sodium Picosulfate Oral Drug Sales Forecast by Country (2027-2032)
- 7.2 North America Sodium Picosulfate Oral Drug Market Size by Country
- 7.2.1 North America Sodium Picosulfate Oral Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Sodium Picosulfate Oral Drug Market Size by Country (2021-2026)
- 7.2.3 North America Sodium Picosulfate Oral Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Sodium Picosulfate Oral Drug Sales by Country
- 8.1.1 Europe Sodium Picosulfate Oral Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Sodium Picosulfate Oral Drug Sales by Country (2021-2026)
- 8.1.3 Europe Sodium Picosulfate Oral Drug Sales Forecast by Country (2027-2032)
- 8.2 Europe Sodium Picosulfate Oral Drug Market Size by Country
- 8.2.1 Europe Sodium Picosulfate Oral Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Sodium Picosulfate Oral Drug Market Size by Country (2021-2026)
- 8.2.3 Europe Sodium Picosulfate Oral Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Sodium Picosulfate Oral Drug Sales by Country
- 9.1.1 Asia-Pacific Sodium Picosulfate Oral Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Sodium Picosulfate Oral Drug Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Sodium Picosulfate Oral Drug Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Sodium Picosulfate Oral Drug Market Size by Country
- 9.2.1 Asia-Pacific Sodium Picosulfate Oral Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Sodium Picosulfate Oral Drug Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Sodium Picosulfate Oral Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Sodium Picosulfate Oral Drug Sales by Country
- 10.1.1 South America Sodium Picosulfate Oral Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Sodium Picosulfate Oral Drug Sales by Country (2021-2026)
- 10.1.3 South America Sodium Picosulfate Oral Drug Sales Forecast by Country (2027-2032)
- 10.2 South America Sodium Picosulfate Oral Drug Market Size by Country
- 10.2.1 South America Sodium Picosulfate Oral Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Sodium Picosulfate Oral Drug Market Size by Country (2021-2026)
- 10.2.3 South America Sodium Picosulfate Oral Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Sodium Picosulfate Oral Drug Sales by Country
- 11.1.1 Middle East and Africa Sodium Picosulfate Oral Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Sodium Picosulfate Oral Drug Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Sodium Picosulfate Oral Drug Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Sodium Picosulfate Oral Drug Market Size by Country
- 11.2.1 Middle East and Africa Sodium Picosulfate Oral Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Sodium Picosulfate Oral Drug Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Sodium Picosulfate Oral Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Sodium Picosulfate Oral Drug Value Chain Analysis
- 12.1.1 Sodium Picosulfate Oral Drug Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Sodium Picosulfate Oral Drug Production Mode & Process
- 12.2 Sodium Picosulfate Oral Drug Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Sodium Picosulfate Oral Drug Distributors
- 12.2.3 Sodium Picosulfate Oral Drug Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst